Bispecific Antibody for Cancer Immunotherapy
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12168695 B2, initially filed July 1, 2022) developed by Hatem Soliman, Tampa, Florida, for "Bispecific antibody for cancer immunotherapy." . . .